NCT00566267View on ClinicalTrials.gov

A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

November 30, 2007

Conditions
Hyperlipidemia
Interventions
DRUG

simvastatin 20 mg/ezetimibe

see protocol

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00566267 - A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet | Biotech Hunter | Biotech Hunter